Use of Stromal Intervention and Exogenous Neoantigen Vaccination to Boost Pancreatic Cancer Chemo-Immunotherapy by Nanocarriers

Despite the formidable treatment challenges of pancreatic ductal adenocarcinoma (PDAC), considerable progress has been made in improving drug delivery via pioneering nanocarriers. These innovations are geared towards overcoming the obstacles presented by dysplastic stroma and fostering anti-PDAC imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Chattopadhyay, Saborni, Liao, Yu-Pei, Wang, Xiang, Nel, André E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604647/
https://www.ncbi.nlm.nih.gov/pubmed/37892935
http://dx.doi.org/10.3390/bioengineering10101205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604647/
https://www.ncbi.nlm.nih.gov/pubmed/37892935
http://dx.doi.org/10.3390/bioengineering10101205

Ejemplares similares